NCT05309668 · Interventional trial
Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions Neurofibromatosis Type 1
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory